# Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine

> **NCT03778580** · NA · COMPLETED · sponsor: **Columbia University** · enrollment: 55 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DIETARY_SUPPLEMENT:** Pyridoxamine Dihydrochloride
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03778580
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03778580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03778580, "Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03778580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*